Richard Lynn Crowther Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 156 S Main St, Brigham City, UT 84302 Phone: 435-734-2027 |
Dr. Sean Lyman, PHARMD. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 156 S Main St, Brigham City, UT 84302 Phone: 435-734-2027 Fax: 435-734-9935 |
Brock Crystal, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1017 Medical Dr, Brigham City, UT 84302 Phone: 435-723-5211 Fax: 435-723-6379 |
Dr. Marc Weston Andersen, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 156 S Main St, Brigham City, UT 84302 Phone: 435-734-2027 Fax: 435-734-9935 |
Mrs. Dee Syndergaard Lunday, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 156 S Main St, Brigham City, UT 84302 Phone: 435-734-2027 Fax: 435-734-9935 |
Dr. Mark Andrew Bennett, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1200 S Commerce Way, Brigham City, UT 84302 Phone: 435-734-9784 |
Amy Heyder, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 156 S Main St, Brigham City, UT 84302 Phone: 435-734-2027 |
Lindsay Jo Cole Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2222 S 385 W, Brigham City, UT 84302 Phone: 435-553-5374 |
Rebecca Petersen, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 770 S 400 E Apt 50, Brigham City, UT 84302 Phone: 435-720-3840 |
News Archive
The drug crizotinib (trade name: Xalkori) has been available since 2012 for patients with advanced non-small cell lung cancer (bronchial carcinoma) who have a high activity of the enzyme anaplastic lymphoma kinase (ALK) and have already received another treatment. In November 2015, the approval was extended to first-line treatment.
Researchers have mapped the precise 3-D atomic structure of a thin protein filament critical for cells in the inner ear and calculated the force necessary to pull it apart.
A team of scientists at the Institut de recherches cliniques de Montr-al (IRCM) led by Dr. Jean-Fran-ois C-t-, Director of the Cytoskeletal Organization and Cell Migration research unit, identified a novel molecular mechanism in the control of cell motility. Their findings were published online today in Current Biology, a journal from the Cell Press group. This scientific breakthrough could eventually lead to the development of new cancer-treating drugs that could block the spread of tumours (metastasis).
A team of US-based scientists has recently conducted a survey to determine the willingness of healthcare workers towards coronavirus disease 2019 (COVID-19) vaccinations.
› Verified 3 days ago